Assessment of the compatibility of the real-world nonvalvular atrial fibrillation patients in Turkey with the study population of Phase 3 novel oral anticoagulant trials: An auxiliary study of NOAC-TR

Assessment of the compatibility of the real-world nonvalvular atrial fibrillation patients in Turkey with the study population of Phase 3 novel oral anticoagulant trials: An auxiliary study of NOAC-TR

Introduction: Although the indication of novel oral anticoagulant (NOAC) treatment in atrial fibrillation (AF) is comparatively similar, Phase 3 NOAC trials have variable inclusion criteria that differentiate each other and also from the real-world population. Aim: We aim to investigate the similari...

Full description

Bibliographic Details
Main Authors: Sadik Volkan Emren, Mehdi Zoghi, Ugur Karagöz, Sinan Inci, Gönül Açiksari, Lütfü Bekar, Zeynep Yapan Emren, Oktay Ergene
Format: Article
Language:English
Published: Galenos Publishing House 2020-01-01
Series:International Journal of the Cardiovascular Academy
Subjects:
atrial fibrillation
cha2ds2–vasc score
chads2score
novel oral anticoagulants
Online Access:http://www.ijcva.com/article.asp?issn=2405-8181;year=2020;volume=6;issue=1;spage=12;epage=15;aulast=Emren

Internet

http://www.ijcva.com/article.asp?issn=2405-8181;year=2020;volume=6;issue=1;spage=12;epage=15;aulast=Emren

Similar Items